![Paul Spence](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Spence
Corporate Officer/Principal chez
HALOZYME THERAPEUTICS, INC.
Profil
Mr. Paul Spence is a Chief Commercial Officer at Halozyme Therapeutics, Inc. Mr. Spence was previously employed as a Chief Commercial Officer by OptiNose, Inc., a Senior VP & Chief Commercial Officer-US by Aimmune Therapeutics, Inc., a Vice President-US Commercial by Nestle Health Science SA, and an Executive Director-Go to Market Models by Boehringer Ingelheim Pharmaceuticals, Inc. He received his undergraduate degree from The Pennsylvania State University and an MBA from Villanova University.
Postes actifs de Paul Spence
| Sociétés | Poste | Début |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2025 |
Anciens postes connus de Paul Spence
| Sociétés | Poste | Fin |
|---|---|---|
| OPTINOSEPAR | Corporate Officer/Principal | 21/05/2025 |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2022 |
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Corporate Officer/Principal | 01/01/2019 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01/06/2016 |
Formation de Paul Spence
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
